Occudo Quantitative Strategies LP Harrow Health, Inc. Transaction History

Occudo Quantitative Strategies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $43,128 - $67,873	-3,074 Reduced 20.92%	11,617 $166,000
Q2 2023 Aug 14, 2023	SELL	$17.37 - $28.08 $40,194 - $64,977	-2,314 Reduced 13.61%	14,691 $279,000
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $235,349 - $364,927	17,005 New	17,005 $359,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $68,636 - $259,921	10,447 New	10,447 $126,000
Q1 2022 May 16, 2022	SELL	$6.77 - $8.66 $77,394 - $99,001	-11,432 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $56,975 - $80,436	-6,703 Reduced 36.96%	11,432 $99,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $5,459 - $8,278	781 Added 4.5%	18,135 $165,000
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $6,185 - $10,250	-926 Reduced 5.07%	17,354 $161,000
Q1 2021 May 14, 2021	BUY	$6.26 - $11.03 $114,432 - $201,628	18,280 New	18,280 $123,000

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.